Literature DB >> 8236334

Incidence of silent cerebral infarction in patients with major depression.

T Fujikawa1, S Yamawaki, Y Touhouda.   

Abstract

BACKGROUND AND
PURPOSE: There have been few studies of the incidence of silent cerebral infarction detected by magnetic resonance imaging in patients with presenile or senile major depression.
METHODS: We examined silent cerebral infarction in patients with presenile and senile major depression who were diagnosed at Hiroshima Prefectural Hospital. The diagnostic criteria of the American Psychiatric Association (DSM-III-R) were used. Patients with stroke or focal neurological symptoms were excluded.
RESULTS: Silent cerebral infarction was observed in 51.4% of the patients with presenile-onset presenile depression, and the incidence was significantly higher than in patients with juvenile-onset presenile depression (P < .01). Among the patients with senile major depression, silent cerebral infarction was observed in 65.9% of those with presenile-onset depression and in 93.7% of those with senile-onset depression.
CONCLUSIONS: Our findings suggest that half of presenile-onset major depression and the majority of senile-onset major depression might be organic depression related to silent cerebral infarction. Because major depression occurring for the first time during or after the presenile period may be related to silent cerebral infarction, it is important to keep this possibility in mind when treating such patients.

Entities:  

Mesh:

Year:  1993        PMID: 8236334     DOI: 10.1161/01.str.24.11.1631

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  38 in total

Review 1.  Mood, cognition and in vivo protein imaging: the emerging nexus in clinical neuroscience.

Authors:  Anand Kumar; Olusola Ajilore; Vladimir Kepe; Jorge R Barrio; Gary Small
Journal:  Int J Geriatr Psychiatry       Date:  2008-06       Impact factor: 3.485

Review 2.  The impact of vascular burden on late-life depression.

Authors:  Micaela Santos; Enikö Kövari; Patrick R Hof; Gabriel Gold; Constantin Bouras; Panteleimon Giannakopoulos
Journal:  Brain Res Rev       Date:  2009-09-08

3.  Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial.

Authors:  Yvette I Sheline; Carl F Pieper; Deanna M Barch; Kathleen Welsh-Bohmer; Kathleen Welsh-Boehmer; Robert C McKinstry; James R MacFall; Gina D'Angelo; Keith S Garcia; Kenneth Gersing; Consuelo Wilkins; Warren Taylor; David C Steffens; Ranga R Krishnan; P Murali Doraiswamy
Journal:  Arch Gen Psychiatry       Date:  2010-03

Review 4.  The vascular depression hypothesis: mechanisms linking vascular disease with depression.

Authors:  W D Taylor; H J Aizenstein; G S Alexopoulos
Journal:  Mol Psychiatry       Date:  2013-02-26       Impact factor: 15.992

5.  Depression, quality of life, and medical resource utilization in sickle cell disease.

Authors:  Soheir S Adam; Charlene M Flahiff; Shital Kamble; Marilyn J Telen; Shelby D Reed; Laura M De Castro
Journal:  Blood Adv       Date:  2017-10-12

Review 6.  Biological risk factors for late life depression.

Authors:  Henning Tiemeier
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

7.  White-matter tract integrity in late-life depression: associations with severity and cognition.

Authors:  R A Charlton; M Lamar; A Zhang; S Yang; O Ajilore; A Kumar
Journal:  Psychol Med       Date:  2013-09-16       Impact factor: 7.723

Review 8.  Risk of "silent stroke" in patients older than 60 years: risk assessment and clinical perspectives.

Authors:  Jae-Sung Lim; Hyung-Min Kwon
Journal:  Clin Interv Aging       Date:  2010-09-07       Impact factor: 4.458

Review 9.  Implications of silent strokes.

Authors:  Frank M Yatsu; Hashem M Shaltoni
Journal:  Curr Atheroscler Rep       Date:  2004-07       Impact factor: 5.113

Review 10.  Treatment of stroke in older patients. A state of the art review.

Authors:  G Harper
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.